• Freshpet management's commentary attributed third-quarter 2026 net sales growth of 10% to higher volumes, with revenue reaching $317.8 million.
• Adjusted gross margin rose 400 basis points to 50%, driven by plant expense leverage, reduced quality costs and lower relative input costs.
• Adjusted EBITDA increased approximately 18% to $64.5 million as higher sales and gross profit outweighed increased overhead, including logistics costs.
• Management raised full-year sales growth guidance to 12%-13% from 10%-12%, lifting the adjusted EBITDA outlook to $215 million-$220 million from $210 million-$220 million.
• Capital spending guidance fell to $125 million-$150 million from approximately $150 million as manufacturing productivity gains enabled investment deferrals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Freshpet Inc. published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.